Lynx Biosciences, Inc.
San Diego, USA
|
Description:
Lynx Biosciences (LynxBio) is developing technologies to predict the efficacy of chemotherapies for multiple myeloma (MM) and other blood cancer patients. LynxBio's product, MicroC3™, is a test that rapidly analyzes the therapeutic response of MM patients’ tumor cells with their own non-tumor cells.
Lynx Biosciences (LynxBio) is developing technologies to predict the efficacy of chemotherapies for multiple myeloma (MM) and other blood cancer patients. LynxBio's product, MicroC3™, is a test that rapidly analyzes the therapeutic response of MM patients’ tumor cells with their own non-tumor cells.